Claudio Gobbi

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis

Giulio Disanto, Christian Barro, Pascal Benkert et al. · Annals of Neurology · 2017 · 1.2K citations · Full text

Life Sciences, Neurology, Neuroscience +16

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Christian Barro, Pascal Benkert, Giulio Disanto et al. · Brain · 2018 · 534 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

Stéphanie Meier, Eline A.J. Willemse, Sabine Schaedelin et al. · JAMA Neurology · 2023 · 275 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis

Alessandro Cagol, Sabine Schaedelin, Muhamed Baraković et al. · JAMA Neurology · 2022 · 176 citations · Full text

Life Sciences, Neurology, Neuroscience +13